Antacid Medications for Ulcers and GERD: The Importance of Quality Testing Before Distribution

The term “indigestion” may refer to several complaints, including upper abdominal discomfort, nausea, bloating, fullness, or burning after meals. Gastroesophageal reflux disease, or GERD, occurs when stomach contents repeatedly flow back into the esophagus, causing symptoms such as heartburn and regurgitation.

Antacid medications are commonly used to provide relief from acid-related symptoms. They generally contain aluminum-, magnesium-, calcium-, or sodium-based compounds that chemically neutralize gastric acid. Although antacid medications can provide rapid relief, their role in GERD is mainly to manage occasional symptoms rather than to treat the underlying cause or replace medical assessment for persistent symptoms.

Antacid medications products are available as chewable tablets, effervescent tablets, powders, and oral suspensions. Even when two products contain similar active ingredients, they may differ in their neutralizing capacity, speed of action, physical stability, dose consistency, and ease of use.

This is where pharmaceutical quality testing becomes essential. Testing demonstrates that an antacid medications does not merely have an acceptable appearance and taste, but also performs as intended and remains within specification throughout its shelf life.

Table of Content:

• Acid-Neutralizing Capacity as a Key Quality Attribute
• Confirming Active-Ingredient Content and Consistency
• Testing Chewable and Effervescent Tablets
• Quality Testing of Antacid Medications Suspensions
• Why Must Product Stability Be Demonstrated?
• Safety and Labeling Considerations
• Quality Testing Before Market Release

Acid-Neutralizing Capacity as a Key Quality Attribute

One of the most important antacid medications quality parameters is acid-neutralizing capacity, or ANC. It represents the amount of gastric acid that can theoretically be neutralized by a specified dose of the product.

Products with apparently similar active ingredients do not necessarily provide the same ANC. The type and amount of active compound, particle size, dosage form, excipient composition, and manufacturing process can all influence product performance.

Studies of marketed antacid medications have identified differences in ANC among formulations and dosage forms. Aluminum hydroxide and magnesium hydroxide combinations demonstrated relatively high neutralizing capacity in one evaluation, while oral suspensions produced different results compared with tablet and effervescent forms.

The FDA antacid medications monograph also refers to a pharmacopeial procedure for measuring acid-neutralizing capacity. This demonstrates that the amount of active ingredient stated on the label is not sufficient on its own; the performance of the finished product must also be verified.

Read Also:
Topical vs Oral Medications: Believe It or Not, Differences Matter!

Confirming Active-Ingredient Content and Consistency

Antacid medications formulations may contain one or more active ingredients, including aluminum hydroxide, magnesium hydroxide, calcium carbonate, magnesium carbonate, or sodium bicarbonate. Some formulations may also contain alginates or antiflatulent ingredients.

Identity and assay testing confirm that the correct active ingredients are present at concentrations that meet the product specification. Dose consistency must also be maintained between individual tablets and between successive measured doses of a suspension.

Poor distribution of active materials may cause consumers to receive different amounts despite following the same labeled instructions.

Testing Chewable and Effervescent Tablets

For antacid medications tablets, quality evaluation extends beyond active-ingredient assay. Physical properties can directly affect manufacturing performance, product handling, and consumer use.

Testing may include:

• Appearance and organoleptic characteristics
• Weight variation
• Dose or content uniformity
• Tablet hardness
• Friability
• Disintegration
• Moisture content
• Acid-neutralizing capacity

A tablet that is excessively hard may be difficult to chew or may disintegrate slowly. A tablet with inadequate mechanical strength may break during production, packaging, transportation, or handling.

Moisture control is particularly important for effervescent tablets. Exposure to humidity may initiate a premature reaction between acidic and carbonate components.

This may cause swelling, texture changes, impaired dissolution, or reduced performance. Moisture testing, dissolution time, packaging integrity, and stability evaluation are therefore important for these products.

Quality Testing of Antacid Medications Suspensions

Antacid suspensions contain active particles that are not fully dissolved in the liquid vehicle. These particles may settle during storage.

Sedimentation can be acceptable provided that the product can be shaken and returned to a uniform dispersion. A major concern is the formation of a compact sediment or cake that cannot be readily redispersed.

This may cause the active ingredient to accumulate at the bottom of the container, producing inconsistent doses during use.

Relevant suspension tests may include:

• Appearance, color, odor, and taste
• Active-ingredient identity and assay
• pH
• Viscosity and flow behavior
• Particle size
• Sedimentation volume
• Redispersibility
• Density
• Deliverable volume
• Acid-neutralizing capacity
• Microbial limits
• Preservative effectiveness, where applicable

Viscosity must be carefully balanced. A product that is too fluid may sediment rapidly, while a highly viscous suspension may be difficult to pour, measure, and shake. Suspension-formulation principles require settled particles to remain readily redispersible so that consistent dosing can be maintained.

Why Must Product Stability Be Demonstrated?

During storage and distribution, pharmaceutical products may be exposed to temperature, humidity, light, air, and mechanical vibration. These factors may alter the physical, chemical, or microbiological characteristics of a product.

Potential changes in antacid products include:

• Softening, cracking, or discoloration of tablets
• Premature reactions in effervescent tablets
• Excessive sedimentation or caking in suspensions
• Changes in pH or viscosity
• Reduced active content or neutralizing capacity
• Changes in flavor or odor
• Reduced preservative effectiveness
• Interactions between the formulation and packaging

Stability studies assess how the quality of a pharmaceutical product changes over time under the influence of environmental factors. The resulting data support shelf-life assignment, storage instructions, specifications, and packaging selection.

The stability program should evaluate physical, chemical, and microbiological attributes that may influence product quality, safety, or performance.

Safety and Labeling Considerations

Different mineral-based antacids have different characteristics. Magnesium-containing products may have a laxative effect in some users, while aluminum- or calcium-based products may contribute to constipation.

Sodium content should also be considered, particularly in effervescent formulations and products intended for consumers who need to restrict sodium intake. Antacids medications may also interact with other medicines.

Changes in gastric pH and complex formation with aluminum, magnesium, or calcium ions can reduce the absorption of certain drugs, including several antibiotics. Formulation composition, dosage instructions, warnings, and recommendations regarding administration intervals should therefore be supported by appropriate data and scientific assessment.

Quality Testing Before Market Release

Quality testing enables manufacturers to demonstrate consistent characteristics across production batches. Testing data may also support:

• Selection of the most stable formulation
• Comparison of product prototypes
• Determination of ANC per dose
• Manufacturing-process evaluation
• Packaging selection
• Shelf-life and storage-condition establishment
• Product specifications and claims
• Reduction of product nonconformities and consumer complaints

An antacid mediations product should not be considered acceptable solely because it contains substances known to neutralize acid. The finished product must demonstrate the correct active dose, adequate distribution, appropriate neutralizing capacity, and stability throughout its intended shelf life.

Ensure Antacid Quality, Stability, and Performance Before Marketing

Quality testing provides scientific evidence that an antacid medications product can deliver consistent and reliable performance. Discuss your requirements for acid-neutralizing capacity, active-ingredient assay, physical quality, microbiological evaluation, and stability testing with IML Testing & Research.

Author: Lina
Editor: Lina

References

Yafout, M., Elhorr, H., Sbai El Otmani, I., & Khayati, Y. (2022). Evaluation of the acid-neutralizing capacity and other properties of antacids marketed in Morocco. Medicine and Pharmacy Reports, 95(1), 80–87.

Garg, V., Narang, P., & Taneja, R. (2022). Antacids revisited: Review on contemporary facts and relevance for self-management. Journal of International Medical Research, 50(3).

Lin, M. S., Sun, P., & Yu, H. Y. (1998). Evaluation of buffering capacity and acid-neutralizing pH time profile of antacids. Journal of the Formosan Medical Association, 97(10), 704–710.

aylor, K. M. G., & Aulton, M. E. (Eds.). (2021). Aulton’s Pharmaceutics: The Design and Manufacture of Medicines (6th ed.).

Elsevier. Qiu, Y., Chen, Y., Zhang, G. G. Z., Yu, L., & Mantri, R. V. (Eds.). (2017). Developing Solid Oral Dosage Forms: Pharmaceutical Theory and Practice (2nd ed.). Academic Press.